->

I-Tag: GlaxoSmithKline

Ikhaya / Unyaka Omisiwe

Dostarlimab Jemperli
, ,

I-Dostarlimab-gxly ene-chemotherapy igunyazwe yi-FDA yomdlavuza we-endometrial

Agasti 2023: I-Dostarlimab-gxly (Jemperli, GlaxoSmithKline), elandelwa yi-dostarlimab-gxly njenge-ejenti eyodwa, yagunyazwa i-Food and Drug Administration ukuze zelashwe umdlavuza we-endometrial othuthukile noma ophindelelayo (EC..

i-jemperli
, , ,

I-Dostarlimab-gxly igunyazwe yi-FDA ngomdlavuza we-endometrial we-dMMR

Feb 2023: I-Dostarlimab-gxly (i-Jemperli, i-GlaxoSmithKline LLC) yanikezwa imvume ye-FDA yokwelapha iziguli ezikhulile ezinomdlavuza ophindaphindayo noma othuthukile we-endometrial oqhubeke noma ngemva kwalokho.

, , , ,

Bonke ababambiqhaza ocwaningweni oluncane lomdlavuza bathole ukuthethelelwa okuphelele

NgoJuni 2022: Ucwaningo oluncane lweziguli ezinomdlavuza we-rectal luveze imiphumela emangalisayo: amaphesenti ayi-100 abantu ayexolelwe. Imiphumela yashicilelwa ku-New England Journal of Medicine kuleli sonto.Isivivinyo sixhaswe ngezimali ..

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton